Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Attention Deficit Disorder with Hyperactivity 1

Interventions

pembrolizumab 18Paclitaxel 15Cisplatin 14Carboplatin 13Radiation 11Nivolumab 10Doxorubicin 10Cyclophosphamide 10Radiotherapy 9Vincristine 8Metformin 7Fluorouracil 7Etoposide 7Cytarabine 7tislelizumab 6Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Leucovorin 6Injections 6Docetaxel 6Bevacizumab 6atezolizumab 5Prednisone 5Pemetrexed 5Oxaliplatin 5Methotrexate 5Lenalidomide 5Irinotecan 5Ipilimumab 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Acetylcysteine × 30 days × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡